Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

Abstract Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases. This type of swelling is bradykinin mediated and does not respond to antihistamines, corticosteroids, or epinephrine. The symptoms usually appear in patients older than 40 years with recurrent episodes of angioedema without wheals. The family history is negative. The swelling could affect any tissue, but most frequently is located at the face, lips, tongue, larynx, or extremities. In the gastrointestinal tract, it causes pain, nausea, vomiting, and diarrhea. The upper respiratory airway oedema is a potentially life-threatening condition due to asphyxiation. The oedema attacks may precede the symptoms of the causative disease for months or years. In most cases, the treatment of the underlying disease resolves the angioedema episodes. Here we report a case of C1-INH-AAE caused by non-Hodgkin lymphoma in a patient diagnosed many years before with myasthenia gravis whose angioedema symptoms resolved after the specific treatment of lymphoma.

[1]  H. Farkas,et al.  A follow‐up survey of patients with acquired angioedema due to C1‐inhibitor deficiency , 2020, Journal of internal medicine.

[2]  K. Bork,et al.  Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate , 2019, Orphanet Journal of Rare Diseases.

[3]  M. Cicardi,et al.  Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency. , 2017, The journal of allergy and clinical immunology. In practice.

[4]  A. Banerji,et al.  Acquired C1 Inhibitor Deficiency. , 2017, Immunology and allergy clinics of North America.

[5]  M. Wu,et al.  The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity , 2016, Clinical chemistry and laboratory medicine.

[6]  K. van Besien,et al.  Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature , 2012, Leukemia & lymphoma.

[7]  H. Iwasaki,et al.  Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma , 2005, Annals of Hematology.

[8]  A. Gajra,et al.  Response of myasthenia gravis to rituximab in a patient with non‐Hodgkin lymphoma , 2004, American journal of hematology.

[9]  J. Piette,et al.  Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. , 2002, The American journal of medicine.

[10]  B. Zweiman,et al.  Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. , 1976, Blood.